Cargando…
Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis
BACKGROUND: Salmonella is a leading cause of foodborne enterocolitis worldwide. Nontyphoidal Salmonella (NTS) infections that are Multi-Drug-resistant (MDR) (non-susceptible to ≥1 agent in ≥3 antimicrobial categories) may result in more severe health outcomes, although these effects have not been sy...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631758/ http://dx.doi.org/10.1093/ofid/ofx163.645 |
_version_ | 1783269551552593920 |
---|---|
author | Parisi, Andrea Crump, John A Kirk, Martyn Glass, Kathryn Howden, Benjamin Gray, Darren Furuya-Kanamori, Luis Vilkins, Samantha |
author_facet | Parisi, Andrea Crump, John A Kirk, Martyn Glass, Kathryn Howden, Benjamin Gray, Darren Furuya-Kanamori, Luis Vilkins, Samantha |
author_sort | Parisi, Andrea |
collection | PubMed |
description | BACKGROUND: Salmonella is a leading cause of foodborne enterocolitis worldwide. Nontyphoidal Salmonella (NTS) infections that are Multi-Drug-resistant (MDR) (non-susceptible to ≥1 agent in ≥3 antimicrobial categories) may result in more severe health outcomes, although these effects have not been systematically examined. We conducted a systematic review and meta-analysis to examine impacts of MDR NTS on disease outcomes in high-income settings. METHODS: We systematically reviewed the literature from scientific databases, including PubMed, Scopus and grey literature sources, using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We included case–control studies, cohorts, outbreaks, and theses, imposing no language restriction. We included only publications from 1 January 1990 through 15 September 2016 from high-income countries as classified by the World Bank, and extracted data on duration of illness, hospitalization, morbidity and mortality of MDR and susceptible NTS infections. RESULTS: After we removed duplicates, the initial search revealed 4 258 articles. After further screening, we identified 16 eligible studies for the systematic review, but due to inconsistency in the compared groups, only 9 of these were included in the meta-analysis. NTS serotypes differed among the reported studies but serotypes Typhimurium, Enteritidis, Newport, and Heidelberg were the most often reported MDR pathogens. Salmonella infections that were MDR were associated with excess bloodstream infections (OR 1·73; 95% CI 1·32–2·27), excess hospitalizations (OR 2·51; 95% CI 1·38–4·58), and higher mortality (OR 3·54; 95% CI 1·10–11·40). CONCLUSION: The results of this meta-analysis suggest that MDR NTS infections have more serious health outcomes compared with susceptible isolates. With the emergence of MDR Salmonella strains in high-income countries, it is crucial to restrict the use of antimicrobials in animals and humans, and intervene to prevent foodborne infections. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-5631758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56317582017-11-07 Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis Parisi, Andrea Crump, John A Kirk, Martyn Glass, Kathryn Howden, Benjamin Gray, Darren Furuya-Kanamori, Luis Vilkins, Samantha Open Forum Infect Dis Abstracts BACKGROUND: Salmonella is a leading cause of foodborne enterocolitis worldwide. Nontyphoidal Salmonella (NTS) infections that are Multi-Drug-resistant (MDR) (non-susceptible to ≥1 agent in ≥3 antimicrobial categories) may result in more severe health outcomes, although these effects have not been systematically examined. We conducted a systematic review and meta-analysis to examine impacts of MDR NTS on disease outcomes in high-income settings. METHODS: We systematically reviewed the literature from scientific databases, including PubMed, Scopus and grey literature sources, using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We included case–control studies, cohorts, outbreaks, and theses, imposing no language restriction. We included only publications from 1 January 1990 through 15 September 2016 from high-income countries as classified by the World Bank, and extracted data on duration of illness, hospitalization, morbidity and mortality of MDR and susceptible NTS infections. RESULTS: After we removed duplicates, the initial search revealed 4 258 articles. After further screening, we identified 16 eligible studies for the systematic review, but due to inconsistency in the compared groups, only 9 of these were included in the meta-analysis. NTS serotypes differed among the reported studies but serotypes Typhimurium, Enteritidis, Newport, and Heidelberg were the most often reported MDR pathogens. Salmonella infections that were MDR were associated with excess bloodstream infections (OR 1·73; 95% CI 1·32–2·27), excess hospitalizations (OR 2·51; 95% CI 1·38–4·58), and higher mortality (OR 3·54; 95% CI 1·10–11·40). CONCLUSION: The results of this meta-analysis suggest that MDR NTS infections have more serious health outcomes compared with susceptible isolates. With the emergence of MDR Salmonella strains in high-income countries, it is crucial to restrict the use of antimicrobials in animals and humans, and intervene to prevent foodborne infections. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631758/ http://dx.doi.org/10.1093/ofid/ofx163.645 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Parisi, Andrea Crump, John A Kirk, Martyn Glass, Kathryn Howden, Benjamin Gray, Darren Furuya-Kanamori, Luis Vilkins, Samantha Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis |
title | Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis |
title_full | Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis |
title_fullStr | Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis |
title_short | Health Outcomes from Multi-Drug-resistant Salmonella Infections in High-Income Countries: A Systematic Review and Meta-Analysis |
title_sort | health outcomes from multi-drug-resistant salmonella infections in high-income countries: a systematic review and meta-analysis |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631758/ http://dx.doi.org/10.1093/ofid/ofx163.645 |
work_keys_str_mv | AT parisiandrea healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis AT crumpjohna healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis AT kirkmartyn healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis AT glasskathryn healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis AT howdenbenjamin healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis AT graydarren healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis AT furuyakanamoriluis healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis AT vilkinssamantha healthoutcomesfrommultidrugresistantsalmonellainfectionsinhighincomecountriesasystematicreviewandmetaanalysis |